Europe Central Nervous System Therapeutic Market Size & Outlook
Europe central nervous system therapeutic market, 2018-2028 (US$M)
Related Markets
Europe central nervous system therapeutic market highlights
- The Europe central nervous system therapeutic market generated a revenue of USD 31,475.1 million in 2020.
- The market is expected to grow at a CAGR of 6.6% from 2021 to 2028.
- In terms of segment, mental health was the largest revenue generating disease in 2020.
- Neurodegenerative Diseases is the most lucrative disease segment registering the fastest growth during the forecast period.
- Country-wise, Spain is expected to register the highest CAGR from 2021 to 2028.
Europe data book summary
| Market revenue in 2020 | USD 31,475.1 million |
| Market revenue in 2028 | USD 52,668.3 million |
| Growth rate | 6.6% (CAGR from 2020 to 2028) |
| Largest segment | Mental health |
| Fastest growing segment | Neurodegenerative Diseases |
| Historical data covered | 2018 - 2019 |
| Base year for estimation | 2020 |
| Forecast period covered | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Neurovascular Diseases, CNS Trauma, Mental Health, Neurodegenerative Diseases, Infectious Diseases, CNS Cancer |
| Key market players worldwide | Biogen Inc, Otsuka Pharmaceutical, Eli Lilly and Co, Merck & Co Inc, AstraZeneca PLC, Novartis AG ADR, Teva Pharmaceutical Industries Ltd, Johnson & Johnson, Pfizer Inc |
Other key industry trends
- In terms of revenue, Europe region accounted for 29.7% of the global central nervous system therapeutic market in 2020.
- Globally, North America is projected to lead the regional market in terms of revenue in 2028.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 43,984.7 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Central Nervous System Therapeutic Market Scope
Central Nervous System Therapeutic Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe central nervous system therapeutic market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to central nervous system therapeutic market will help companies and investors design strategic landscapes.
Mental health was the largest segment with a revenue share of 45.2% in 2020. Horizon Databook has segmented the Europe central nervous system therapeutic market based on neurovascular diseases, cns trauma, mental health, neurodegenerative diseases, infectious diseases, cns cancer covering the revenue growth of each sub-segment from 2018 to 2028.
Neurological diseases, including those of the CNS, account for a large and increasing health burden in Europe. Stroke, migraine, and other neurological diseases are among the most common types in Europe after cardiovascular diseases and cancers.
The region’s aging population is one of the factors driving prevalence of neurodegenerative diseases. The prevalence of Alzheimer’s disease, multiple sclerosis, and Parkinson’s disease is comparatively higher in the European region.
Moreover, the incidence of mental health disorders is increasing in the region. These disorders, which mainly include anxiety, depression, and drug-related issues, affect 1 in 6 Europeans in any given year and cost more than 4% of the GDP across 28 EU countries.
Reasons to subscribe to Europe central nervous system therapeutic market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe central nervous system therapeutic market databook
-
Our clientele includes a mix of central nervous system therapeutic market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe central nervous system therapeutic market , including forecasts for subscribers. This continent databook contains high-level insights into Europe central nervous system therapeutic market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
Europe central nervous system therapeutic market size, by country, 2018-2028 (US$M)
Europe Central Nervous System Therapeutic Market Outlook Share, 2020 & 2028 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
